GlassScriptPhysician profile
Cameron Stephenson
NPI 1174080402
$13,447.22
in general payments reported to CMS, 2019-2025
54 companies · $2,569 in 2025
The $2,569 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,567 · 2022: $2,214 · 2023: $2,823 · 2024: $4,274 · 2025: $2,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,665 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,664.50 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,519.46 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $1,392.09 | 2021-2025 | Ultomiris, Soliris |
| Neurocrine Biosciences, INC. | $1,109.34 | 2022-2025 | Ingrezza, Ongentys |
| Ucb, INC. | $1,036.64 | 2022-2025 | Rystiggo, Briviact, Nayzilam |
| Abbvie INC. | $854.46 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $573.39 | 2021-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Lilly USA, LLC | $560.39 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Argenx US, INC. | $473.58 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $380.18 | 2021-2024 | Vyepti |
| Sk Life Science, INC. | $378.62 | 2022-2025 | Xcopri |
| Takeda Pharmaceuticals U.S.A., INC. | $371.56 | 2023-2025 | Hyqvia, Trintellix, Gammagard |
| Acorda Therapeutics, INC | $320.82 | 2021-2024 | Inbrija, Ampyra |
| Eisai INC. | $293.21 | 2021-2024 | |
| Amgen INC. | $253.44 | 2021-2025 | Repatha, Uplizna, Aimovig |
| Astrazeneca Pharmaceuticals LP | $249.34 | 2021-2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $233.25 | 2021-2025 | Nuplazid |
| Neurelis, INC. | $181.26 | 2022-2025 | Valtoco |
| Genentech USA, INC. | $173.24 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Biohaven Pharmaceuticals, INC. | $171.26 | 2021 | |
| Avanir Pharmaceuticals, INC. | $170.44 | 2022 | |
| Jazz Pharmaceuticals INC. | $157.07 | 2023-2025 | |
| Medtronic, INC. | $145.40 | 2022-2023 | Linq II |
| Tg Therapeutics, INC. | $144.21 | 2023-2024 | |
| Abbott Laboratories | $140.11 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Melinta Therapeutics, LLC | $125.00 | 2022 | |
| Emd Serono, INC. | $124.57 | 2021-2025 | |
| Scpharmaceuticals INC. | $121.89 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2024 | Evkeeza |
| Novo Nordisk INC | $121.81 | 2025 | |
| Chiesi USA, INC. | $120.95 | 2025 | Cleviprex |
| Kyowa Kirin, INC. | $111.75 | 2022-2024 | Nourianz |
| Baxter Healthcare | $110.70 | 2024 | Starling System |
| Tanabe Pharma America, INC. | $107.12 | 2021-2024 | |
| Catalyst Pharmaceuticals, INC. | $104.11 | 2023-2024 | Fycompa, Firdapse |
| Csl Behring | $100.54 | 2022-2024 | Hizentra |
| Smith+Nephew, INC. | $99.27 | 2023 | Tc-100 |
| Mallinckrodt Hospital Products INC. | $93.60 | 2025 | Terlivaz |
| Biogen, INC. | $87.20 | 2021-2025 | Leqembi |
| Cvrx, INC. | $84.78 | 2022 | |
| Pfizer INC. | $78.11 | 2024-2025 | |
| Amneal Pharmaceuticals LLC | $56.07 | 2022-2023 | Rytary |
| Vanda Pharmaceuticals INC. | $52.42 | 2024 | Ponvory |
| Sunovion Pharmaceuticals INC. | $47.30 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $42.85 | 2023 | Rexulti, Nuedexta |
| Genzyme Corporation | $42.62 | 2021-2022 | |
| Cycle Pharmaceuticals INC | $35.02 | 2024 | Tascenso Odt |
| Supernus Pharmaceuticals, INC. | $33.83 | 2021 | |
| Averitas Pharma INC. | $24.12 | 2023 | Qutenza |
| Greenwich Biosciences, INC. | $23.89 | 2021 | |
| Janssen Biotech, INC. | $23.13 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.31 | 2024 | Keveyis |
| Boston Scientific Corporation | $18.20 | 2023 | |
| Bioventus LLC | $16.75 | 2024 | L300 Go System |
| Janssen Pharmaceuticals, INC | $14.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Stephenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.